Compiled from "Capital Market" data; For companies with year ending on March 31, 9 months ended December 31, 2003, EPS data has been annualised for companies with year ending December 31 2003, full year EPS has been used.
For the year ended March 31, 2003; Source for other companies: "Capital Market" Volume XVIII/22 dated January 5, 2004 to January 18, 2004 for the Category: Pharmaceutical - Indian Bulk Drugs & Formulations.
Compiled from "Capital Market" data; For companies with year ending on March 31, 9 months ended December 31 2003, EPS data has been annualised;for companies with year ending December 31, 2003, full year EPS has been used.
IPO Review by Members
BIOCON IPO Reviews, analysis and views by popular members.
Review By
Apply
May Apply
Not Rated
Avoid
Count
0
0
0
0
%
0.00
0.00
0.00
0.00
Member
Review
No recommendation found. Be the first to post the recommendation.
The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.
